-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In the past 10 years, the incidence of gonorrhoea has increased dramatically in many countries.
In the past 10 years, the incidence of gonorrhoea has increased dramatically in many countries.
The OMEGA trial is a multi-center, parallel group, double-blind, randomized controlled trial.
diagnosis
From March 30, 2016 to October 26, 2018, a total of 786 MSM were screened , and 256 of them were excluded.
Screening
The incidence of oropharyngeal gonorrhea in the two groups
The incidence of oropharyngeal gonorrhea in the two groupsOut of 227 MSM in the Biotène group, 10 (4%) detected oropharyngeal gonorrhoea, while 15 out of 219 MSM in the Listerine group (7%) detected oropharyngeal gonorrhea (adjusted risk difference 2.
Out of 227 MSM in the Biotène group, 10 (4%) detected oropharyngeal gonorrhoea, while 15 out of 219 MSM in the Listerine group (7%) detected oropharyngeal gonorrhea (adjusted risk difference 2.
Proportion of men with Neisseria gonorrhoeae detected and adjusted risk
Proportion of men with Neisseria gonorrhoeae detected and adjusted riskIn short, compared with Biotène mouthwash, Listerine mouthwash does not reduce the incidence of oropharyngeal gonorrhea .
Compared with Biotène mouthwash, Listerine mouthwash does not reduce the incidence of oropharyngeal gonorrhea
Original source:
Original source:Eric PF Chow, et al.
org/10.
1016/S1473-3099(20)30704-0" target="_blank" rel="noopener">Antiseptic mouthwash for gonorrhoea prevention (OMEGA) : a randomised, double-blind, parallel-group, multicentre trial in this message
